Endologix Inc. Reports 25% Third Quarter 2011 Revenue Growth

October 28, 2011 |

1 min read

IRVINE, Calif., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2011.

Earnings

MORE ON THIS TOPIC

cutting off a row of people into pieces

Layoffs

Editas Axes 60% of Staff, Sickle Cell Therapy After Failing to Find Partner

December 13, 2024

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff

December 12, 2024

·

205 min read

·

BioSpace Editorial Staff

Podcast

Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More

December 11, 2024

·

1 min read

·

Heather McKenzie

Group Of Employees Being Fired By Their Company.

Layoffs

Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline

December 10, 2024

·

2 min read

·